1. Industry
Send to a Friend via Email

Your suggestion is on its way!

An email with a link to:


was emailed to:

Thanks for sharing About.com with others!

You can opt-out at any time. Please refer to our privacy policy for contact information.

The 27 New Drugs Approved by the FDA in 2013


10 of 20

Invokana for type 2 diabetes

Invocana package information

Johnson & Johnson

Johnson & Johnson's Invokana received FDA approval on March 29, 2013.

Invokana is a once-a-day treatment for controlling blood sugar in adults with type 2 diabetes. According to the FDA, it is the first in a new class of diabetes drugs called  sodium-glucose co-transporter 2 (SGLT2) inhibitors.

Invokana blocks the re-absorption of glucose by the kidney, increases glucose excretion, and lowers blood glucose levels in diabetics with elevated blood glucose levels.

Generic name: canagliflozin

FDA announcement: FDA approves Invokana to treat type 2 diabetes

Product website: invokana.com


©2014 About.com. All rights reserved.